McKesson Corporation
MCK
Rang in Aktien
#190
McKesson Corporation is a prominent global provider of healthcare services,... McKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organized into four key business segments. The U.S. Pharmaceutical division plays a crucial role in the distribution of a comprehensive array of pharmaceutical products, encompassing branded, generic, specialty, biosimilar, and over-the-counter medications, alongside other health-related merchandise. This segment also delivers specialized support to community-based oncology and other specialty medical practices through practice management tools, technology solutions, clinical guidance, and broader business services. Furthermore, it assists pharmacies with consulting, outsourcing, and technology services, while also furnishing financial, operational, and clinical software solutions. Internationally, the company's dedicated segment provides distribution and support services to wholesale, institutional, and retail clients across 13 European nations and Canada. The Medical-Surgical Solutions unit is focused on supplying healthcare providers with essential medical-surgical products, sophisticated logistics management, and a variety of associated services. Finally, the Prescription Technology Solutions (RxTS) segment is designed to address complex medication challenges for patients. It collaborates with biopharmaceutical companies and life sciences partners to improve patient journeys, leveraging innovative solutions for medication access and adherence by connecting pharmacies, healthcare providers, payers, and biopharma entities. This segment further offers third-party logistics and wholesale distribution assistance. Founded in 1833, McKesson Corporation maintains its corporate headquarters in Irving, Texas.
Aktienkurs
$1,005.18
Zuletzt synchronisiert: 2026-10-16
Marktkapitalisierung
$117.19B
Veränderung (1 Tag)
0.83%
Veränderung (1 Jahr)
27.89%
Land
US
Handel McKesson Corporation (MCK)
Kategorie
Healthcare
Operative Marge für McKesson Corporation (MCK)
Operative Marge zum October 2026 TTM: 1.62%
Laut den neuesten Finanzberichten und dem Aktienkurs von McKesson Corporation beträgt die aktuelle operative Marge (TTM) 1.62%. Am Ende des Jahres 2024 lag die operative Marge bei 1.27%.
Historie der operativen Marge von McKesson Corporation von 2000 bis 2026
Operative Marge zum Jahresende
| Jahr | Operative Marge | ändert |
|---|---|---|
| 2026 (TTM) | 1.62% | 32.79% |
| 2025 | 1.22% | -3.94% |
| 2024 | 1.27% | -21.12% |
| 2023 | 1.61% | 56.31% |
| 2022 | 1.03% | -29.93% |
| 2021 | 1.47% | 13.08% |
| 2020 | 1.30% | -9.72% |
| 2019 | 1.44% | 2.86% |
| 2018 | 1.40% | -17.16% |
| 2017 | 1.69% | -16.34% |
| 2016 | 2.02% | 2.54% |
| 2015 | 1.97% | 2.07% |
| 2014 | 1.93% | -2.53% |
| 2013 | 1.98% | 2.06% |
| 2012 | 1.94% | 3.74% |
| 2011 | 1.87% | 1.08% |
| 2010 | 1.85% | 14.91% |
| 2009 | 1.61% | 11.03% |
| 2008 | 1.45% | 5.07% |
| 2007 | 1.38% | 3.76% |
| 2006 | 1.33% | 6.40% |
| 2005 | 1.25% | -11.35% |
| 2004 | 1.41% | -13.50% |
| 2003 | 1.63% | 17.27% |
| 2002 | 1.39% | 504.35% |
| 2001 | 0.23% | -46.51% |
| 2000 | 0.43% | 0.00% |
Operative Marge vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Operative Marge | Differenz der operativen Marge | Land |
|---|---|---|---|
| 0.00% | - |
US
|
|
| 1.03% | -99.36% |
US
|
|
| 0.00% | - |
US
|
|
| 9.21% | -94.31% |
AU
|
|
| 5.69% | -96.49% |
US
|
Was ist die operative Marge eines Unternehmens?
Die operative Marge ist ein wichtiger Indikator zur Bewertung der Rentabilität eines Unternehmens. Höhere operative Margen sind in der Regel besser, da sie zeigen, dass ein Unternehmen seine Produkte oder Dienstleistungen mit deutlichem Gewinn über den Produktionskosten verkauft. Die operative Marge wird berechnet, indem der Gewinn des Unternehmens durch seinen Umsatz geteilt wird.